Broadwing Bio is advancing antibody therapies to treat common causes of vision loss. Focused on genetically validated targets, our goal is to develop best-in-disease therapies to meaningfully preserve eyesight for glaucoma and geographic atrophy patients.
Company Details
- Employees
- 5
- Address
- 171 Oyster Point Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.broadwing.bio/
- Keywords
- IT Consulting.
- HQ
- South San Francisco, California
Broadwing Bio Questions
Broadwing Bio's website is https://www.broadwing.bio/
Broadwing Bio's LinkedIn profile is https://www.linkedin.com/company/broadwing-bio
Broadwing Bio has
5 employees.
View email and phone details for 5
employees at Broadwing Bio.
Broadwing Bio's industry is
Biotechnology Research
Broadwing Bio's top competitors are
Broadwing Labs,
Broadwing Capital,
Aldebaran Therapeutics,
Alloy Therapeutics, Inc.,
Cytomed Therapeutics Limited,
Biora Therapeutics,
Arda Therapeutics,
Broadwing,
Sagimet Biosciences,
Hillstar Bio.
Broadwing Bio's categories are Biotechnology Research
